Unique Ingredient Identifier 8Z96QXD6UM is listed as a ingredient substance
| RN | 77-93-0 |
| EC | 201-070-7 |
| NCIT | C76736 |
| RXCUI | 1310554 |
| PUBCHEM | 6506 |
| MF | C12H20O7 |
| INCHI KEY | DOOTYTYQINUNNV-UHFFFAOYSA-N |
| SMILES | CCOC(=O)CC(O)(CC(=O)OCC)C(=O)OCC |
UNII 8Z96QXD6UM TRIETHYL CITRATE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| INTRAMUSCULAR | INJECTABLE | 2.4 mg |
| INTRAMUSCULAR | INJECTION | 10.4 mg |
| ORAL | CAPSULE | 16 MG |
| ORAL | CAPSULE, COATED | 2.18 MG |
| ORAL | CAPSULE, COATED PELLETS | 0.59 MG |
| ORAL | CAPSULE, DELAYED ACTION | 17.92 MG |
| ORAL | CAPSULE, DELAYED RELEASE | 16.825 mg |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 45 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 22.23 MG |
| ORAL | CAPSULE, FILM COATED, EXTENDED RELEASE | 0.939 MG |
| ORAL | CAPSULE, HARD GELATIN | 4 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 7.5 MG |
| ORAL | CAPSULE, SUSTAINED ACTION, HARD GELATIN | 3.3 MG |
| ORAL | GRANULE, FOR ORAL SUSPENSION | 6.94 MG |
| ORAL | LIQUID,EXTENDED RELEASE | 0.42 MG/ML |
| ORAL | PELLET | 3.8 MG |
| ORAL | SUSPENSION | 8.27 MG/15 ML |
| ORAL | SUSPENSION, SUSTAINED ACTION | 6.94 MG/.20684GM |
| ORAL | TABLET | 2.3 mg |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 2.8 MG |
| ORAL | TABLET, CONTROLLED RELEASE | 2.269 mg |
| ORAL | TABLET, DELAYED ACTION | 15.1 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 20.18 MG |
| ORAL | TABLET, DELAYED RELEASE | 12.26 mg |
| ORAL | TABLET, EXTENDED RELEASE | 14.3 MG |
| ORAL | TABLET, FILM COATED | 3.6 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 4 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 18.7 MG |
| ORAL | TABLET, SUSTAINED ACTION | 2.28 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 0.5 MG |